Dr. Philip Friedlander, MD

Bio

Specialties:

Affiliation:

  • The Mount Sinai Health System, Icahn School of Medicine at Mount Sinai

Location:

  • Mount Sinai Doctors Faculty Practice
  • 1470 Madison Avenue
  • New York, NY
  • 212-241-6756
  • View Contact Info

Group Memberships:

Activity

  • Sharecare News
    Sharecare News posted a story about Cardiology:

    THURSDAY, July 31, 2014 (HealthDay News) -- They may not have had fast food, TVs or cigarettes, but people of ancient times commonly developed clogged heart arteries -- and a new research review speculates on some reasons why.

    Using CT scans of mummified remains...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    MONDAY, July 28, 2014 (HealthDay News) -- Approved use for Imbruvica (ibrutinib) has been expanded to include people with chronic lymphocytic leukemia (CLL) who have a deletion in chromosome 17, the U.S. Food and Drug Administration said Monday in a news release.

    People with the 17p dele...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    FRIDAY, July 25, 2014 (HealthDay News) -- Although cervical cancers are declining in the United States and Canada, other cancers linked to human papillomavirus (HPV) are increasing, a new study indicates.

    HPV-related cancers of the anus and the base of the tongue and tonsils have increase...Full Article

  • Sharecare News
    Sharecare News posted a story about Transplantation Medicine:

    WEDNESDAY, July 23, 2014 (HealthDay News) -- Most blood cancer patients in the United States who need a bone marrow transplant can find an acceptable match through the National Marrow Donor Program, a new study has determined.

    Depending on a patient's race or ethnic background, the study ...Full Article

  • Sharecare News
    Sharecare News posted a story about Hematology:

    WEDNESDAY, July 23, 2014 (HealthDay News) -- Zydelig (idelalisib) has been approved by the U.S. Food and Drug Administration to treat relapsed forms of blood cancer, including chronic lymphocytic leukemia (CLL), follicular B-cell non-Hodgkin lymphoma (FL) and small lymphocytic lymphoma (SLL), the

    ...Full Article
  • Sharecare News
    Sharecare News posted a story about Dermatology:

    WEDNESDAY, July 23, 2014 (HealthDay News) -- Painful or itchy skin lesions could be a warning sign of skin cancer, researchers report.

    "Patients sometimes have multiple lesions that are suspicious looking, and those that are itchy or painful should raise high concerns for non-melanoma ski...Full Article

  • Sharecare News
    Sharecare News posted a story about Obstetrics & Gynecology:

    FRIDAY, July 18, 2014 (HealthDay News) -- A new study involving data on more than 1 million women finds the HPV test outperforming the standard Pap test in assessing cervical cancer risk.

    Researchers at the U.S. National Cancer Institute (NCI) conclude that a negative test for HPV (human ...Full Article

  • Sharecare News
    Sharecare News posted a story about Urology:

    FRIDAY, July 11, 2014 (HealthDay News) -- Prostate cancer patients are more likely to be diagnosed with aggressive disease, receive less effective treatment and die sooner if they also have depression, a new study suggests.

    Researchers analyzed data from more than 41,200 American men who ...Full Article

  • Sharecare News
    Sharecare News posted a story about Obstetrics & Gynecology:

    WEDNESDAY, July 9, 2014 (HealthDay News) -- The drug exemestane worked slightly better than the drug tamoxifen at preventing a recurrence of breast cancer in certain premenopausal women, according to a new study.

    Almost 93 percent of women on exemestane (Aromasin) remained free of breast ...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    THURSDAY, July 3, 2014 (HealthDay News) -- Beleodaq (belinostat) has been approved by the U.S. Food and Drug Administration to treat peripheral T-Cell lymphoma (PTCL), a rare and aggressive form of non-Hodgkin lymphoma (cancer of the lymph nodes).

    Some 70,800 Americans will be diagnosed w...Full Article

  • Sharecare News
    Sharecare News posted a story about Hepatology:

    TUESDAY, July 1, 2014 (HealthDay News) -- Although it looked promising in early studies, the drug everolimus didn't improve survival for people with advanced liver cancer in its latest trial, a new study found.

    The findings from the phase 3 clinical trial are disappointing because earlie...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    TUESDAY, July 1, 2014 (HealthDay News) -- While medications are helping HIV-positive people avoid developing full-blown AIDS indefinitely, a new study finds that cancer patients with HIV are up to four times less likely to be treated for their tumors.

    The research comes with caveats. It l...Full Article

  • Sharecare News
    Sharecare News posted a story about Mental Health:

    MONDAY, June 30, 2014 (HealthDay News) -- A medication commonly used to treat HIV appears to double the risk that patients will develop suicidal thoughts or take their lives, new research contends.

    The finding concerns the anti-HIV drug efavirenz, which is marketed as Sustiva.

    Pr...Full Article

  • Sharecare News
    Sharecare News posted a story about Infectious Disease:

    MONDAY, June 30, 2014 (HealthDay News) -- A combination drug used to treat and prevent HIV -- Truvada -- may have an additional benefit: lowering the risk of a genital herpes infection, a new study suggests.

    Researchers found that African heterosexuals who were at risk of getting HIV from...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    THURSDAY, June 26, 2014 (HealthDay News) -- People who take low-dose aspirin for more than 10 years might be reducing their risk for pancreatic cancer, a new study suggests.

    Even taking a daily aspirin for just three years lowered the chances of the deadly cancer by 48 percent, the resear...Full Article